DE69501080T2 - Verfahren zur herstellung von 7-trialkylsilyl baccatin iii - Google Patents
Verfahren zur herstellung von 7-trialkylsilyl baccatin iiiInfo
- Publication number
- DE69501080T2 DE69501080T2 DE69501080T DE69501080T DE69501080T2 DE 69501080 T2 DE69501080 T2 DE 69501080T2 DE 69501080 T DE69501080 T DE 69501080T DE 69501080 T DE69501080 T DE 69501080T DE 69501080 T2 DE69501080 T2 DE 69501080T2
- Authority
- DE
- Germany
- Prior art keywords
- baccatin iii
- process according
- trialkylsilyl
- iii
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- OVMSOCFBDVBLFW-VHLOTGQHSA-N 5beta,20-epoxy-1,7beta,13alpha-trihydroxy-9-oxotax-11-ene-2alpha,4alpha,10beta-triyl 4,10-diacetate 2-benzoate Chemical compound O([C@@H]1[C@@]2(C[C@H](O)C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)O)C(=O)C1=CC=CC=C1 OVMSOCFBDVBLFW-VHLOTGQHSA-N 0.000 title description 6
- 238000004519 manufacturing process Methods 0.000 title 1
- YWLXLRUDGLRYDR-ZHPRIASZSA-N 5beta,20-epoxy-1,7beta,10beta,13alpha-tetrahydroxy-9-oxotax-11-ene-2alpha,4alpha-diyl 4-acetate 2-benzoate Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](O)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-ZHPRIASZSA-N 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 20
- -1 alkyl radicals Chemical class 0.000 claims abstract description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims abstract description 3
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical compound C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 claims abstract description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 18
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 6
- RQMWVVBHJMUJNZ-UHFFFAOYSA-N 4-chloropyridin-2-amine Chemical group NC1=CC(Cl)=CC=N1 RQMWVVBHJMUJNZ-UHFFFAOYSA-N 0.000 claims description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 229930014667 baccatin III Natural products 0.000 description 4
- 239000000047 product Substances 0.000 description 3
- 238000006884 silylation reaction Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 230000021736 acetylation Effects 0.000 description 2
- 238000006640 acetylation reaction Methods 0.000 description 2
- DCFKHNIGBAHNSS-UHFFFAOYSA-N chloro(triethyl)silane Chemical compound CC[Si](Cl)(CC)CC DCFKHNIGBAHNSS-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229940123237 Taxane Drugs 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical group C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C07F7/1872—Preparation; Treatments not provided for in C07F7/20
- C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C07F7/1872—Preparation; Treatments not provided for in C07F7/20
- C07F7/188—Preparation; Treatments not provided for in C07F7/20 by reactions involving the formation of Si-O linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epoxy Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Silicon Compounds (AREA)
- Saccharide Compounds (AREA)
- Liquid Deposition Of Substances Of Which Semiconductor Devices Are Composed (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Cephalosporin Compounds (AREA)
- Silicon Polymers (AREA)
- Steroid Compounds (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Internal Circuitry In Semiconductor Integrated Circuit Devices (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9403979A FR2718137B1 (fr) | 1994-04-05 | 1994-04-05 | Procédé de préparation de trialcoylsilyl-7 baccatine III. |
| PCT/FR1995/000419 WO1995026967A1 (fr) | 1994-04-05 | 1995-04-03 | Procede de preparation de trialcoylsilyl-7 baccatine iii |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69501080D1 DE69501080D1 (de) | 1998-01-02 |
| DE69501080T2 true DE69501080T2 (de) | 1998-04-02 |
Family
ID=9461745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69501080T Expired - Lifetime DE69501080T2 (de) | 1994-04-05 | 1995-04-03 | Verfahren zur herstellung von 7-trialkylsilyl baccatin iii |
Country Status (33)
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5973160A (en) * | 1992-12-23 | 1999-10-26 | Poss; Michael A. | Methods for the preparation of novel sidechain-bearing taxanes |
| US7288665B1 (en) | 1997-08-18 | 2007-10-30 | Florida State University | Process for selective derivatization of taxanes |
| EP1019347B1 (en) * | 1997-08-21 | 2003-03-19 | Florida State University | Method for the synthesis of taxanes |
| JP2004525860A (ja) | 2000-09-22 | 2004-08-26 | ブリストル−マイヤーズ スクイブ カンパニー | 併用化学療法剤の毒性を低下させる方法 |
| ITMI20012185A1 (it) * | 2001-10-19 | 2003-04-19 | Indena Spa | Procedimento per la preparazione della 14beta-idrossi-baccatina iii-1,14-carbonato |
| ITMI20012186A1 (it) * | 2001-10-19 | 2003-04-19 | Indena Spa | Procedimento per la preparazione della 14-beta-idrossi-baccatina iii-1,14-carbonato |
| AU2003273671A1 (en) * | 2002-10-09 | 2004-05-04 | Phytogen Life Sciences, Inc. | Novel taxanes and methods related to use and preparation thereof |
| US7202370B2 (en) * | 2003-10-27 | 2007-04-10 | Conor Medsystems, Inc. | Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III |
| WO2005113528A1 (en) * | 2004-05-14 | 2005-12-01 | Immunogen, Inc. | A facile method for synthesizing baccatin iii compounds |
| CZ298333B6 (cs) * | 2005-09-26 | 2007-08-29 | Zentiva, A. S | Zpusob prípravy 7-trialkylsilylbaccatinu III |
| KR101671537B1 (ko) | 2008-08-11 | 2016-11-01 | 넥타르 테라퓨틱스 | 다분지형 중합체 알카노에이트 컨쥬게이트 |
| US20130331443A1 (en) | 2010-12-22 | 2013-12-12 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of taxane-based compounds |
| US10894087B2 (en) | 2010-12-22 | 2021-01-19 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds |
| US9199954B2 (en) | 2010-12-22 | 2015-12-01 | Nektar Therapeutics | Non-ring hydroxy substituted taxanes and methods for synthesizing the same |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4823167A (en) * | 1986-12-16 | 1989-04-18 | Baxter International Inc. | Catheter calibration device |
| FR2629818B1 (fr) * | 1988-04-06 | 1990-11-16 | Centre Nat Rech Scient | Procede de preparation du taxol |
| MX9102128A (es) | 1990-11-23 | 1992-07-08 | Rhone Poulenc Rorer Sa | Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene |
| US5229526A (en) * | 1991-09-23 | 1993-07-20 | Florida State University | Metal alkoxides |
| US5597931A (en) * | 1992-03-30 | 1997-01-28 | Sloan-Kettering Institute For Cancer Research | Total synthesis of taxol and analogues thereof |
| US5475011A (en) * | 1993-03-26 | 1995-12-12 | The Research Foundation Of State University Of New York | Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment |
| US5405972A (en) * | 1993-07-20 | 1995-04-11 | Florida State University | Synthetic process for the preparation of taxol and other tricyclic and tetracyclic taxanes |
| US5449790A (en) * | 1994-04-06 | 1995-09-12 | Hauser Chemical Research, Inc. | Preparation of 10-deacetylbaccatin III and 7-protected-10-deacetylbaccatin III derivatives from 10-deacetyl taxol A, 10-deacetyl taxol B, and 10-deacetyl taxol C |
-
1994
- 1994-04-05 FR FR9403979A patent/FR2718137B1/fr not_active Expired - Fee Related
-
1995
- 1995-03-22 TW TW084102793A patent/TW284765B/zh not_active IP Right Cessation
- 1995-04-03 EP EP95916696A patent/EP0754185B1/fr not_active Expired - Lifetime
- 1995-04-03 CN CN95192429A patent/CN1058497C/zh not_active Expired - Lifetime
- 1995-04-03 KR KR1019960705642A patent/KR100399246B1/ko not_active Expired - Fee Related
- 1995-04-03 CA CA002186916A patent/CA2186916C/fr not_active Expired - Lifetime
- 1995-04-03 AT AT95916696T patent/ATE160351T1/de active
- 1995-04-03 EE EE9600143A patent/EE03240B1/xx unknown
- 1995-04-03 PL PL95316588A patent/PL316588A1/xx unknown
- 1995-04-03 AU AU23096/95A patent/AU683560B2/en not_active Expired
- 1995-04-03 DK DK95916696.8T patent/DK0754185T3/da active
- 1995-04-03 ZA ZA952733A patent/ZA952733B/xx unknown
- 1995-04-03 ES ES95916696T patent/ES2109103T3/es not_active Expired - Lifetime
- 1995-04-03 US US08/722,103 patent/US5670658A/en not_active Expired - Lifetime
- 1995-04-03 CZ CZ19962900A patent/CZ288397B6/cs not_active IP Right Cessation
- 1995-04-03 BR BR9507444A patent/BR9507444A/pt not_active IP Right Cessation
- 1995-04-03 GE GEAP19953433A patent/GEP19991537B/en unknown
- 1995-04-03 JP JP52546695A patent/JP3718225B2/ja not_active Expired - Lifetime
- 1995-04-03 MX MX9604466A patent/MX9604466A/es unknown
- 1995-04-03 DE DE69501080T patent/DE69501080T2/de not_active Expired - Lifetime
- 1995-04-03 WO PCT/FR1995/000419 patent/WO1995026967A1/fr not_active Ceased
- 1995-04-03 HU HU9602735A patent/HU214158B/hu unknown
- 1995-04-03 SK SK1265-96A patent/SK280448B6/sk not_active IP Right Cessation
- 1995-04-03 RU RU96120192/04A patent/RU2127729C1/ru active
- 1995-04-03 UA UA96093735A patent/UA44730C2/uk unknown
- 1995-04-03 NZ NZ284490A patent/NZ284490A/en not_active IP Right Cessation
- 1995-04-03 RO RO96-01921A patent/RO115631B1/ro unknown
-
1996
- 1996-09-24 LT LT96-137A patent/LT4185B/lt not_active IP Right Cessation
- 1996-09-27 NO NO964103A patent/NO305839B1/no not_active IP Right Cessation
- 1996-10-04 FI FI964001A patent/FI115970B/fi not_active IP Right Cessation
- 1996-10-04 BG BG100886A patent/BG62735B1/bg unknown
- 1996-10-07 LV LVP-96-392A patent/LV11691B/lv unknown
-
1997
- 1997-11-20 GR GR970401504T patent/GR3025448T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69208395T2 (de) | Zwischenprodukte für die Synthese von 19-Nor Vitamin D Verbindungen | |
| DE602004007145T2 (de) | Regioselektive synthese von cci-779 | |
| DE68906705T2 (de) | Verfahren zur herstellung von baccatin-iii-derivaten und von desacetyl-10-baccatin-iii. | |
| EP0638575B1 (de) | Verfahren zur Herstellung von Diorganodialkoxysilanen | |
| DE2240311C3 (de) | Verfahren zur Herstellung von ungesättigten cyvloaliphatischen Estern | |
| JP3718225B2 (ja) | ７−トリアルキルシリルバッカチン▲ｉｉｉ▼の製造法 | |
| DE69725700T2 (de) | Verfahren zur Herstellung von Baccatin III und seiner Derivate ausgehend von 10-Deacetylbaccatin III. | |
| DE69616798T2 (de) | Durch c-2'-hydroxyl-benzyl und n-carbamat geschützte (2r,3s)-3-phenylisoserine und verfahren zu deren herstellung | |
| DE69621463T2 (de) | Verfahren zum ausgewähltem schutz von baccatinderivaten und ihre verwendung für die synthese von taxanen | |
| DE3127989C2 (de) | 20-Isocyano-3-methoxy-pregna-3,5,17(20)-trien, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung von 17alpha-Hydroxy-progesteron | |
| DE69503366T2 (de) | Verfahren zu herstellung von 7-hydroxy taxane | |
| DE69410856T2 (de) | Verfahren zur Herstellung von optisch aktiven Beta-hydroxy-ketonen | |
| DE3884445T2 (de) | Acylierungsverfahren für die Synthese von HMG-COA-Reductase-Inhibitoren. | |
| DE60030483T2 (de) | Ein verfahren zur herstellung von simvastatin | |
| DE68921306T2 (de) | Verfahren zur Herstellung von 4-Acyloxy-2-azetidinon-Derivaten. | |
| DE60120991T2 (de) | Verfahren zu herstellung von discodermoliden und ähnlichen verbindungen | |
| DE60004054T2 (de) | Neue verfahren zur herstellung von 17beta-hydroxy-17alpha-methyl-2-oxa-5alpha-androstane-3-on | |
| DE3408196C2 (enExample) | ||
| DE69416117T2 (de) | Verfahren zur herstellung von kondensierten carbapenemderivaten | |
| CH635057A5 (de) | Verfahren zur herstellung von tricycloheptan-6-onen. | |
| DE4336429C1 (de) | Verfahren zur Herstellung von Zwischenprodukten innerhalb der Vitamin D- oder Vitamin D-Derivat-Synthesen | |
| EP1196427B1 (de) | C-19-halogensubstituierte, 5-substituierte oder 6,10-carbozyklisch-kondensierte steroide der androst-9(11)-en-reihe, verfahren zu ihrer herstellung sowie ihre verwendung | |
| DE69301345T2 (de) | Verfahren zur Herstellung von 4-Deoxy-D-Mannose | |
| DE69208888T2 (de) | N-trityl asparaginsäurederivate zur herstellung von phosphonat nmda antagonisten | |
| DE68915213T2 (de) | Verfahren zur Herstellung von Vitamin A oder ihren Carbonsäure-Estern. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: AVENTIS PHARMA S.A., ANTONY, FR |
|
| 8328 | Change in the person/name/address of the agent |
Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN |
|
| 8328 | Change in the person/name/address of the agent |
Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC |